Identification of the Major Degradation Pathways of Selumetinib.
Pharmaceutics
; 14(12)2022 Nov 30.
Article
in En
| MEDLINE
| ID: mdl-36559146
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
Language:
En
Journal:
Pharmaceutics
Year:
2022
Document type:
Article
Affiliation country:
France
Country of publication:
Switzerland